M. Furuhashi

发表

Axin Facilitates Smad3 Activation in the Transforming Growth Factor β Signaling Pathway

Yusuke Nakamura, Ken Yagi, Kohei Miyazono, 2001, Molecular and Cellular Biology.

Platelet-derived growth factor production by B16 melanoma cells leads to increased pericyte abundance in tumors and an associated increase in tumor growth rate.

T. Sjöblom, C. Heldin, C. Betsholtz, 2004, Cancer research.

Highly Active Antiretroviral Therapy Attenuates Re-Endothelialization and Alters Neointima Formation in the Rat Carotid Artery After Balloon Injury

C. Heldin, S. Rosenkranz, G. Fätkenheuer, 2006, Journal of acquired immune deficiency syndromes.

Identification of a subset of pericytes that respond to combination therapy targeting PDGF and VEGF signaling

C. Heldin, C. Hellberg, Y. Hasumi, 2007, International journal of cancer.

Tumors and an Associated Increase in Tumor Growth Rate Melanoma Cells Leads to Increased Pericyte Abundance in Platelet-Derived Growth Factor Production by B 16 Updated

T. Sjöblom, C. Heldin, C. Betsholtz, 2004 .

Lymphoid enhancer factor 1 makes cells resistant to transforming growth factor beta-induced repression of c-myc.

T. Noda, K. Miyazono, Hiroyuki Suzuki, 2003, Cancer research.

c-myc Is a Downstream Target of the Smad Pathway* 210

Ken Yagi, Kohei Miyazono, K. Miyazono, 2002, The Journal of Biological Chemistry.

Normal nephrogenesis occurs in the early stage of bilateral multicystic dysplastic kidneys

M. Furuhashi, H. Kawai, J. Chaya, 2002, Archives of Gynecology and Obstetrics.

Improving chemotherapeutic drug penetration in melanoma by imatinib mesylate.

S. Shimada, T. Kawamura, M. Furuhashi, 2008, Journal of dermatological science.

Successful use of etretinate for long‐term management of a patient with cutaneous‐type adult T‐cell leukaemia/lymphoma

H. Mitsui, N. Shibagaki, Y. Nakamura, 2005, The British journal of dermatology.